肿liu淋巴管归巢肽LyP-1修饰负载核酸/药物的靶向脂质体

【中文名称】

肿liu淋巴管归巢肽LyP-1修饰负载核酸/药物的靶向脂质体

【英文名称】

Targeted liposome coated withLyP-1

【纯   度】

95%以上

【保    存】

4℃保存

【规  格】

50mg，10mg/ml

【产品特性】

LyP-1 是一种环状 9 个氨基酸的肿liu的定位肽，在多种肿liu相关细胞中，选择性结合其 p32 receptor 蛋白。

LyP-1 (8?weeks) shows a remarkable reduction in plaque formation and plaque occupation rates in the LyP-1-treated group. In addition, a higher apoptotic rate in macrophages released from hypoxic plaques is observed after the treatment of LyP-1when compared to control peptide^[1] .
The LyP-1 peptide is labeled with a near-infrared fluorophore (Cy5.5) for optical imaging.
At days 3, 7, 14 and 21 after inoculation with 4T1 cells, tumor-bearing BALB/C mice is injected Cy5.5-LyP-1 (0.8 nmol) through the middle phalanges of the upper extremities of the tumor-bearing mice. The fluorescence intensities were 0.024, 0.038, 0.048 and 0.106×10⁶ photon/cm²/sec respectively at days 3, 7, 14 and 21 after tumor cell inoculation, which are 1.02, 1.63, 2.04, and 4.52-fold higher than in the contralateral LNs. Cy5.5-LyP-1 staining in LNs co-localized with LYVE-1, suggesting lymphatics-specific binding of LyP-1 peptide^[1] .

LyP-1 Chemical Structure

CAS No. : 454487-07-1

系列产品（部分）

穿模肽TAT修饰负载核酸的靶向脂质体

穿模肽R8修饰负载核酸的靶向脂质体

靶向肽CRGD修饰负载核酸的靶向脂质体